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In a recent issue of Critical Care, Preissig and Rigby [1] 
surveyed the attitudes and practice habits among 
pediatric intensivists in the US regarding hyperglycemia 
and tight glycemic control (TGC) in critically ill children. 
Th   e authors report a considerable disparity between the 
convictions of the attending physicians and their actual 
daily practices for blood glucose control in the intensive 
care unit (ICU). Ninety-seven percent of the participants 
believed that subsets of critically ill adult patients should 
be treated for hyperglycemia, and 67% were convinced 
that subsets of critically ill children would beneﬁ  t from 
glycemic control. However, only a minority of the centers 
have a standard approach for screening and treating 
hyperglycemia (7%) and 80% lack a standard approach to 
screen for and treat elevated blood glucose levels. Th  is 
study provides, therefore, good examples of the 
discrep  ancy between conviction and practice, of the 
sceptic implementation of available evidence from clinical 
studies, and of poor adoption of oﬃ   cial recommendations 
in daily practice.
Hyperglycemia and glucose variability occur very 
frequently during major surgery and critical illness. Th  ese 
metabolic responses are strongly associated with poor 
outcome in many diﬀ  erent medical conditions in adults, 
children, and neonates. Prospective randomized trials 
comparing conventional blood glucose management with 
age-adjusted TGC in adult surgical [2] and medical [3] 
ICU patients and in pediatric critically ill patients [4] 
demonstrated a beneﬁ  cial  eﬀ   ect on morbidity and 
mortality favoring TGC. Although the debate regarding 
the pursued blood glucose target ranges is ongoing and 
other studies [5] (albeit with a diﬀ  erent study protocol) 
could not conﬁ  rm the results of the previous ‘Leuven’ 
trials, a majority of the medical community is convinced 
that blood glucose really matters, that glycemic 
management and strategy should be performed in 
critically ill patients, and that excessive hyperglycemia 
should be avoided.
However, routine and successful implementation of 
TGC with intensive insulin therapy remains a diﬃ   cult 
hurdle to clear in many ICUs. Among the most promi-
nent reasons for this poor implementation are the fear of 
evoking iatrogenic hypoglycemia and the general belief 
that hypoglycemia, albeit for a brief period, is more 
dangerous and harmful than sustained hyperglycemia. 
Th  is is elegantly demonstrated in the study by Preissig 
and Rigby [1].
Hypoglycemia can be the result of the lack of accuracy 
of the used blood glucose measurement devices, the 
absence or inadequacy of guidelines and protocols to 
steer the insulin therapy to achieve TGC, or both. 
Implementing TGC requires frequent, rapidly available, 
and accurate blood glucose measurements. However, the 
high level of accuracy of blood glucose measurements 
obtained in remote central laboratory facilities or with 
automated blood gas analyzers cannot be reproduced by 
many available bedside blood glucose devices in the 
setting of critically ill patients with a disturbed ‘milieu 
Abstract
A survey among pediatric intensive care physicians 
showed that a great disparity exists between 
physicians’ beliefs regarding hyperglycemia in critically 
ill patients and their daily practices to screen and treat 
hyperglycemia. One of the most prominent reasons 
for hesitating to implement tight glycemic control is 
the fear of evoking iatrogenic hypoglycemia. Results 
from ongoing and future studies focusing on both 
short- and long-term eff  ects of tight glycemic control 
in broad populations of critically ill children can 
provide further strong evidence for implementing 
tight glycemic control. Improving the accuracy of 
bedside blood glucose measurements and developing 
reliable computer algorithms to steer insulin infusions 
can help to overcome the fear of evoking iatrogenic 
hypoglycemia.
© 2010 BioMed Central Ltd
Blood glucose control in the intensive care unit: 
discrepancy between belief and practice
Dirk Vlasselaers*
See related research by Preissig and Rigby, http://ccforum.com/content/14/1/R11
COMMENTARY
*Correspondence: dirk.vlasselaers@uzleuven.be
Department of Intensive Care Medicine, University Hospitals Leuven, Herestraat 
49, B-3000 Leuven, Belgium
Vlasselaers Critical Care 2010, 14:145 
http://ccforum.com/content/14/3/145
© 2010 BioMed Central Ltdinterne’ (for example, acidosis, hypoxia, and hemo-
dilution) [6,7]. Th  e current unavailability of accurate 
bedside blood glucose measurements in many ICU 
departments precludes safe, eﬃ   cient,  and  widespread 
implementation of TGC. Current technology research 
should focus on the development of accurate and easy-
to-use continuous blood glucose measurement equip-
ment for critically ill patients.
TGC with intensive insulin therapy increases the 
workload and responsibility for bedside nurses. Frequent 
blood testing, interpretation of the blood glucose results, 
and ﬁ  nally adapting the insulin infusion are very demand-
ing for ICU staﬀ  . In addition, guidelines and protocols to 
steer the insulin infusion are mostly rough guides and 
experience and intuition are therefore mandatory for 
successful implementation of TGC. In larger ICUs with a 
broad medical and nursing staﬀ  , it can be a real challenge 
to convince, motivate, and train the personnel to 
implement TGC, as demonstrated by Preissig and Rigby 
[1]. To overcome this ‘human’ factor and to avoid the use 
of ineﬃ   cient and impractical guidelines, computerized 
algorithms taking into account the recent evolution of 
blood glucose values, the insulin dose, the caloric intake, 
and perhaps some physiologic and pharmacologic varia-
bles can be a substantial aid [8]. Incorporating an accurate 
continuous blood glucose analyzer validated for critically 
ill patients and an eﬀ  ective, safe, and validated computer 
algorithm into a closed loop system can help to avoid 
harmful clinical errors leading to iatrogenic-induced 
hypoglycemia and to successful implementation of TGC.
Finally, the results of ongoing and future studies 
regarding TGC in critically ill adults and children can 
help to close the gap between physicians’ convictions, 
attitudes, and daily practices and hence improve the 
implementation of TGC. Th  e long-term eﬀ  ects of TGC 
on neurologic and cognitive development and organ 
functions in children are currently being investigated by 
the Leuven clinical research group. Multicenter pros  pec-
tive randomized controlled trials, like the ongoing CHiP 
(Control of Hyperglycemia in Pediatric Intensive Care) 
trial in the UK, will provide further knowledge about this 
intriguing topic.
In conclusion, as shown by Preissig and Rigby, a 
majority of ICU physicians are convinced that diﬀ  erent 
subsets of critically ill patients, whether adults or 
children, could beneﬁ  t from TGC and that this aﬀ  ects 
outcome. However, only a minority of the centers use a 
standard and uniform approach to screen and treat 
hyperglycemia. Th   is con  siderable disparity between 
beliefs and actual practices is explained, at least partially, 
by the fear of evoking hypoglycemia. Strong eﬀ  orts 
should be made to improve the accuracy of bedside blood 
glucose measurements in ICU patients and to develop 
reliable and safe algorithms to steer insulin infusions and 
avoid iatrogenic hypo  glycemia.
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